Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models

Jezabel Rodríguez‐Blanco(Medical University of South Carolina), David J. Robbins(University of Miami)
Journal of Clinical Investigation
June 17, 2024
Cited by 18


Related Papers